NO20042979L - Prodrugs mot D-proliner - Google Patents

Prodrugs mot D-proliner

Info

Publication number
NO20042979L
NO20042979L NO20042979A NO20042979A NO20042979L NO 20042979 L NO20042979 L NO 20042979L NO 20042979 A NO20042979 A NO 20042979A NO 20042979 A NO20042979 A NO 20042979A NO 20042979 L NO20042979 L NO 20042979L
Authority
NO
Norway
Prior art keywords
prolines
prodrugs against
prodrugs
Prior art date
Application number
NO20042979A
Other languages
English (en)
Inventor
Roland Jakob-Roetne
Sonia Maria Poli
Joerg Huwyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20042979L publication Critical patent/NO20042979L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042979A 2001-12-14 2004-07-13 Prodrugs mot D-proliner NO20042979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129793 2001-12-14
PCT/EP2002/013827 WO2003051836A1 (en) 2001-12-14 2002-12-06 Prodrugs to d-prolines

Publications (1)

Publication Number Publication Date
NO20042979L true NO20042979L (no) 2004-07-13

Family

ID=8179542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042979A NO20042979L (no) 2001-12-14 2004-07-13 Prodrugs mot D-proliner

Country Status (26)

Country Link
US (1) US6903129B2 (no)
EP (2) EP1458680A1 (no)
JP (1) JP4192100B2 (no)
KR (1) KR100678785B1 (no)
CN (1) CN100368397C (no)
AR (1) AR038010A1 (no)
AU (1) AU2002361982B2 (no)
BR (1) BR0214932A (no)
CA (1) CA2470037C (no)
GT (1) GT200200275A (no)
HK (1) HK1076100A1 (no)
HR (1) HRP20040494A2 (no)
HU (1) HUP0402600A3 (no)
IL (2) IL162158A0 (no)
MX (1) MXPA04005693A (no)
MY (1) MY129431A (no)
NO (1) NO20042979L (no)
NZ (1) NZ533188A (no)
PA (1) PA8561201A1 (no)
PE (1) PE20030764A1 (no)
PL (1) PL370803A1 (no)
RU (1) RU2305679C2 (no)
TW (1) TWI225400B (no)
UY (1) UY27584A1 (no)
WO (1) WO2003051836A1 (no)
ZA (1) ZA200404546B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313386D0 (en) * 2003-06-10 2003-07-16 Univ London Treatment of disease
UA108227C2 (xx) 2010-03-03 2015-04-10 Антигензв'язуючий білок
RU2530601C2 (ru) * 2012-10-05 2014-10-10 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Ингибитор образования цинк-зависимых димеров бета-амилоида
GB201407506D0 (en) 2014-04-29 2014-06-11 Glaxosmithkline Ip Dev Ltd Novel compound
US9737505B2 (en) 2014-04-29 2017-08-22 Glaxosmithkline Intellectual Property Development Limited Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
GB201518950D0 (en) * 2015-10-27 2015-12-09 Glaxosmithkline Ip Dev Ltd Compound
WO2017072090A1 (en) * 2015-10-27 2017-05-04 Glaxosmithkline Intellectual Property Development Limited Combination therapy
GB202111866D0 (en) 2021-08-18 2021-09-29 Ucl Business Plc Prodrugs for use in the treatment of tissue damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385308B (en) 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
ATE224366T1 (de) * 1997-10-31 2002-10-15 Hoffmann La Roche D-prolinderivate

Also Published As

Publication number Publication date
CA2470037A1 (en) 2003-06-26
BR0214932A (pt) 2004-11-30
HUP0402600A2 (hu) 2005-03-29
KR100678785B1 (ko) 2007-02-05
WO2003051836A1 (en) 2003-06-26
AR038010A1 (es) 2004-12-22
PE20030764A1 (es) 2003-09-11
EP1743884A1 (en) 2007-01-17
US6903129B2 (en) 2005-06-07
RU2004121783A (ru) 2005-05-10
TWI225400B (en) 2004-12-21
IL162158A0 (en) 2005-11-20
KR20040063992A (ko) 2004-07-15
AU2002361982B2 (en) 2008-09-25
TW200409626A (en) 2004-06-16
AU2002361982A1 (en) 2003-06-30
CN100368397C (zh) 2008-02-13
PL370803A1 (en) 2005-05-30
JP4192100B2 (ja) 2008-12-03
ZA200404546B (en) 2006-02-22
HUP0402600A3 (en) 2011-05-30
NZ533188A (en) 2006-07-28
IL162158A (en) 2010-11-30
MXPA04005693A (es) 2004-12-06
US20030134891A1 (en) 2003-07-17
CN1604892A (zh) 2005-04-06
HRP20040494A2 (en) 2005-12-31
GT200200275A (es) 2003-07-30
CA2470037C (en) 2011-06-14
UY27584A1 (es) 2003-07-31
EP1458680A1 (en) 2004-09-22
HK1076100A1 (en) 2006-01-06
PA8561201A1 (es) 2004-03-26
RU2305679C2 (ru) 2007-09-10
MY129431A (en) 2007-03-30
JP2005515211A (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
IS7291A (is) Merkt kirni
DE50204184D1 (de) Espressobrüheinrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE50208022D1 (de) Wischblatt
DE50206021D1 (de) Schlauchklemme
DE50103741D1 (de) Welle-Nabe-Verbindung
DE50204386D1 (de) Kreuztransducer
DE60213050D1 (de) Sicherheitsgurtaufroller
ATE335486T1 (de) Hydrazono-malonitrile
DE1319930T1 (de) Coriolismassendurchflussmesser
DE60217481D1 (de) Sicherheitsgurtaufroller
DE50204551D1 (de) Kugelgelenk
DE50203412D1 (de) Schwenkkolbenverdränger
DE50203984D1 (de) Kugelgelenk
DE50204794D1 (de) Kugelgelenk
ATE355059T1 (de) Isoxazolopyridinone
DE50208029D1 (de) Kugelgelenk
DE60212532D1 (de) Sicherheitsgurtaufroller
DE50201862D1 (de) Messwandler
NO20042979L (no) Prodrugs mot D-proliner
DE60324196D1 (de) Narcistatin-prodrugs
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
FI20011048A (fi) Tilajärjestely
ATA18372001A (de) Gelenksbolzenbaueinheit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application